Influence of HRS9531 on Pharmacokinetics of Metformin in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 5, 2024

Primary Completion Date

December 26, 2024

Study Completion Date

December 26, 2024

Conditions

Type 2 Diabetes

Interventions

DRUG

HRS9531 injection

HRS9531 injection single dose.

DRUG

Metformin Hydrochloride tablets

Metformin Hydrochloride tablets 500mg.

Trial Locations (1)

The Second Affiliated Hospital of Anhui Medical University, Hefei

All Listed Sponsors

lead

Fujian Shengdi Pharmaceutical Co., Ltd.

INDUSTRY

NCT06654960 - Influence of HRS9531 on Pharmacokinetics of Metformin in Healthy Subjects | Biotech Hunter | Biotech Hunter